Movember is proud to announce its latest prostate cancer investment of over $4.9 million. Eighteen grants (16 proposals and 2 ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

Israeli pharmaceutical company RedHill Biopharma has initiated a placebo-controlled Phase II trial to assess the combination ...

I was in a conversation with an elderly male relative recently and was shocked at the number of people we all know, some of them having been in government at the highest level, who succumbed to ...

New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation ...

The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new study.

(RTTNews) - RedHill Biopharma (RDHL) Tuesday announced that it has launched a Phase 2 trial to assess opaganib's ability to enhance darolutamide in treating metastatic castrate-resistant prostate ...

The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening ...

The Government is “looking carefully” at introducing routine screening for prostate cancer as developments in technology are ...

Successful test in breast cancer patients: the active agent digoxin, a cardiac medication, dissolves clusters of circulating breast cancer cells in the blood, thus reducing the risk of metastases ...